Retatrutide: Upcoming New Injectable Weight Loss Medications Changing and Impacting Traditional Dieting [Updated 2025]
What is Retatrutide? Retatrutide is an innovative weight-loss medication currently advancing through clinical trials as of 2025. It functions uniquely as a triple-hormone receptor agonist, targeting three key metabolic hormones: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon (GCG). These hormones significantly influence appetite control, metabolism, and blood sugar regulation. Retatrutide is administered…